Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation

Written by Rafael D. Fonseca MD

Read the full article here

Source: PracticeUpdate
Categories: General Medicine News, Latest Headlines
Tags: , ,
Tweets with this article
PracticeUpdate
#Oncology Story of the Week: Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed #MultipleMyeloma Not Undergoing Autologous Stem Cell Transplantation. Commentary by @Rfonsi1 #mmsm https://t.co/TpSxwak4Fg

Related Articles